Curriculum Vitae

DR. GAN CHYE CHUNG

Medical Lecturer
  • Department of Medicine
    Faculty of Medicine
  • ccgan
  • 03-7967 3502

AREAS OF EXPERTISE


  • NEPHROLOGY

ACADEMIC QUALIFICATION


  • JAPANESE SOCIETY FOR DIALYSIS ACCESS TRAINING PROGRAM, (INTERVENTIONAL NEPHROLOGY)
    Japanese Society for Dialysis Access
  • ISN Interventional Nephrology Scholar, (INTERVENTIONAL NEPHROLOGY)
    International Society of Nephrology
  • FELLOWSHIP IN INTERVENTIONAL NEPHROLOGY (SINGAPORE), (INTERVENTIONAL NEPHROLOGY)
    Singapore General Hospital, Singapore
  • FELLOWSHIP IN NEPHROLOGY (MALAYSIAN BOARD OF NEPHROLOGY), (Nephrology)
    Malaysian Society of Nephrology
  • MRCP(UK) (ESENeph), (Nefrology)
    Royal College of Physicians of London, United Kingdom
  • MRCP
    Royal College of Physicians of Edinburgh, United Kingdom
  • MBBS, (Medicine and Surgery)
    Aimst University

ADMINISTRATIVE DUTIES


  • Clinical Administration
    26 Aug 2023 - 31 Dec 2040 (University Malaya)
  • Coordinator
    17 Jul 2024 - 16 Jul 2026 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    14 Oct 2024 - 15 Oct 2024 (International)
  • Coordinator
    22 Jan 2021 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Examiner for SAQ Dental Year 3 professional examination- 2020/2021
    16 Jul 2021 - 19 Jul 2021 (University Malaya)
  • INVIGILATOR FOR REQUIRED SUMMATIVE ASSESSMENT 1 (RSA1) OSCE 1
    02 Feb 2021 - 02 Feb 2021 (University Malaya)
  • Assistant coordinator/Case finder
    16 Nov 2020 - 19 Nov 2020 (University Malaya)
  • Examiner for SAQ Dental Year 3 professional examination- 2019/2020
    04 Aug 2020 - 04 Aug 2020 (University Malaya)
  • Stage 2 OSCE Examiner
    10 Jun 2020 - 10 Jun 2020 (University Malaya)
  • OSCE STAGE 2 SESI 2018/2019 Examiner
    08 May 2019 - 08 May 2019 (University Malaya)
  • Question creator for UMMP 3.2 End-of-posting Theory and Barrier Exam Sesi 2019/2020
    05 Apr 2019 - 05 Apr 2019 (University Malaya)
  • Examiner for Remedial UMMP 3.1 (Posting C)
    19 Mar 2019 - 19 Mar 2019 (University Malaya)
  • Examiner for UMMP 3.2 INTERNAL MEDICINE Class of 2018/2019 : Posting Remedial
    18 Feb 2019 - 22 Feb 2019 (University Malaya)
  • UMMP 3.2 (POSTING G) EXAMINERS : EOP (07 to 11 JAN 2019)
    08 Jan 2019 - 08 Jan 2019 (University Malaya)
  • UMMP 3.2 Class of 2014/2019: Posting J Examiner
    02 Oct 2018 - 02 Oct 2018 (University Malaya)
  • 3.1 (2nd ATTEMPT) End of Posting Examination, SESI 2017/2018 : Invigilator
    19 Sep 2018 - 19 Sep 2018 (University Malaya)
  • UMMP PBL Case Writer
    15 Mar 2018 - 06 Jun 2018 (University Malaya)
  • 3.2 MBBS 2016/2018, Professional Examination: Invigilator
    12 Apr 2018 - 12 Apr 2018 (University Malaya)

MEMBERSHIPS


  • LIFE MEMBER, TREASURER
    Since 2024 (National)
  • FELLOW OF THE ROYAL COLLEGE OF PHYSICIAN, LONDON (FRCPL), MEMBER
    Since 2023 (International)
  • FELLOW OF THE ROYAL COLLEGE OF PHYSICIAN, EDINBURGH (FRCPE), MEMBER
    Since 2022 (International)
  • MALAYSIAN SOCIETY OF TRANSPLANTATION, MEMBER
    Since 2018 (National)
  • ROYAL COLLEGE OF PHYSICIANS OF LONDON, MEMBER
    2021 to 2022 (International)
  • ASSOCIATION OF BIOMEDICAL LABORATORY PROFESSIONALS, SINGAPORE (ABMLPS), MEMBER
    2019 to 2022 (International)
  • ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, MEMBER
    2015 to 2022 (International)
  • INTERNATIONAL SOCIETY OF NEPHROLOGY, MEMBER
    2020 to 2021 (International)
  • ACADEMY OF MEDICINE MALAYSIA, MEMBER
    2018 to 2021 (National)
  • ERA-EDTA, MEMBER
    2020 to 2020 (International)
  • AMERICAN SOCIETY OF NEPHROLOGY, MEMBER
    2017 to 2020 (International)
  • MALAYSIAN SOCIETY OF NEPHROLOGY, ASSOCIATE MEMBER
    2017 to 2020 (National)

AWARD AND STEWARDSHIP


  • Third prize Oral Presentation Award KLVAC+DASy 2024
    Vascular Society Malaysia and Dialysis Access Synergy, Singapore, 2024 (National)
  • ISN Interventional Nephrology Scholarship Program
    International Society of Nephrology, 2021 (International)
  • Reviewer of the month
    Current Research in Nutrition and Food Science, 2021 (International)
  • Best Paper Award
    Malaysian Society of Gastroenterology and Hepatology, 2020 (National)
  • Anugerah Perkhidmatan Cemerlang Tahun 2016
    Jabatan Kesihatan Negeri Melaka, Kementerian Kesihatan Malaysia, 2017 (District)
  • Anugerah Perkhidmatan Cemerlang Tahun 2011
    Jabatan Kesihatan Negeri Melaka, Kementerian Kesihatan Malaysia, 2012 (District)
  • Anugerah Program 2PC: Pelajar Contoh
    Sekolah Menengah Kebangsaan Gajah Berang, Melaka, 2001 (District)

PUBLICATIONS


Article in Journal
WoS
  1. Gan, Chye Chung; Tan, Ru Yu; Delaney, Christopher L.; Puckridge, Phillip J.; Pang, Suh Chien; Tng, Alvin Ren Kwang; Tan, Chee Wooi; Tan, Chieh Suai; Tan, Alfred Bingchao; Da Zhuang, Kun; Gogna, Apoorva; Tay, Kiang Hiong; Chan, Sze Ling; Yap, Charyl Jia Qi; Chong, Tze Tec; Tang, Tjun Yip (2022). Study protocol for a Prospective, Randomized Controlled trial of stEnt graft and Drug-coated bAlloon Treatment for cephalic arch stenORsis in dysfunctional arteio-venous fistulas (PREDATOR), JOURNAL OF VASCULAR ACCESS. . doi:10.1177/11297298221130897
  2. Goh, En Thong; Gan, Chye Chung; Lim, Soo Kun; Wong, Chew Ming; Lee, Yee Wan; Chew, Chang Chuan; Jalalonmuhali, Maisarah (2022).

    Metabolic Changes In Living Kidney Donors After Donation In University Malaya Medical Centre

    , TRANSPLANTATION PROCEEDINGS. 54(2), 242-247. doi:10.1016/j.transproceed.2022.01.006
  3. Goh, En Thong; Jalalonmuhali, Maisarah; Ng, Kok Peng; Adnan, Ahmad Hafiz Wan Md; Hing, Albert (Wong); Cheng, Shian Feng; Ooi, Shok Hoon; Gan, Chye Chung (2022). The Outcome of the Elderly Living Kidney Donors in a Single Tertiary Center in Malaysia, TRANSPLANTATION PROCEEDINGS. 54(2), 272-277. doi:10.1016/j.transproceed.2021.12.039
  4. Jalalonmuhali, Maisarah; Ng, Kok Peng; Lee, Yee Wan; Gan, Chye Chung; Hing, Albert (Wong); Adnan, Wan Ahmad Hafiz Wan Md; Cheng, Shian Feng; Chew, Chang Chuan; Ooi, Shok Hoon; Wong, Chew Ming; Lim, Soo Kun (2022). The Effects of Different Induction Regimes on Serial Lymphocyte Subsets in Kidney Transplant Recipients: A Single Tertiary Center Experience, TRANSPLANTATION PROCEEDINGS. 54(2), 299-306. doi:10.1016/j.transproceed.2022.01.004
  5. Gan, C. C., Jalalonmuhali, M., Nordin, N. Z., Wahab, M. Z. A., Yahya, R., Ng, K. P., . . . Lim, S. K. (2021). ABO-Incompatible Living-Donor Kidney Transplantation in a Developing Country: A Multicenter Experience in Malaysia. Transplantation Proceedings, 53(3), 856-864. doi: 10.1016/j.transproceed.2020.10.038
  6. Wong, X. Z., Amirah, A., Gan, C. C., Fatiha, S., Maznah, D., Yahya, R., . . . Lim, S. K. (2021). Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications. Nephrology, 26(5), 463-470. doi: 10.1111/nep.13862
  7. Jalalonmuhali, M., Ng, K. P., Shariff, N. H. M., Lee, Y. W., Wong, A. H., Gan, C. C., & Lim, S. K. (2020). One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia. Transplantation Proceedings, 52(6), 1718-1722. doi: 10.1016/j.transproceed.2020.02.140
  8. Jalalonmuhali, Maisarah; Ng, Kok Peng; Wong, Albert Hing; Lee, Yee Wan; Gan, Chye Chung; Wong, Chew Ming; Adnan, Wan Ahmad Hafiz Wan Md; Lim, Soo Kun (2020). SINGLE CENTRE EXPERIENCE ON ULTRA-LOW DOSE THYMOGLOBULIN AS AN INDUCTION AGENT IN LOW IMMUNOLOGICAL RISK LIVING KIDNEY TRANSPLANT RECIPIENTS, TRANSPLANTATION. 104(9), S616-S616
  9. Wong, X. Z., Gan, C. C., Mohamed, R., Yahya, R., Ganapathy, S., Tan, S. S., & Lim, S. K. (2020). Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrology, 21(1), 6. doi: 10.1186/s12882-020-02154-4
Others
  1. Gan, C. C., Tan, R. Y., Cheong, M. A., Pang, S. C., Tng, R. K., Tan, C. W., Lee, L. H., Ng, H. J., Tay, K. H., Chong, T. T., & Tan, C. S. (2023). Efficacy and safety of low dose, weight-based subcutaneous enoxaparin protocol in recurrent arteriovenous access thrombosis. The Journal of Vascular Access. https://doi.org/10.1177/11297298231194102
  2. JALALONMUHALI, M., NG, K.P., MOHD SHARIFF, H. et al. (2020). One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia. Transplantation Proceedings, 1-5.
  3. XZ Wong, CC Gan, R Mohamed, R Yahya, S Ganapathy, SS Tan, SK Lim (2020). Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrol, Nov 13;21(1):480.
  4. Gan, C.C., Nurul, Z.N., Maisarah, J., et. al.(2019). Outcomes of ABO incompatible living donor kidney transplantation: Multi-centre experience in Malaysia. Journal of Clinical and Translational Nephrology, 1, S1-123.
  5. Ong CS, Ng KP, Wong CM, Wan AH, Maisarah, Lim SJ, Albert H, Gan CC, Lee YW, Nur HMS, Lim SK.(2019). Phospholipase A2 Receptor Antibody Among Membranous Nephropathy (MN) Patients in University Malaya Medical Centre. Journal of Clinic al and Translational Nephrology. Volume1,S1-123
Chapter in Books
  1. Kee, Y. S. T., Choo, C. J. J., Woo, K. T., & Tan, C. S. (2023). The Kidney Book (pp. 375-387). World Scientific Publishing Co Pte Ltd.
Other Publications
  1. Faiz, M., Gan, C.C. (2022) Challenges of managing a case of worsening acute kidney injury in active lupus nephritis with superimposed COVID-19 Infection: A case report. Journal of Clinical And Translational Nephrology. 2(2),1-5. - Case Study
  2. Maisarah, J.;Kok Peng, Ng; Albert Hing, W; Yee Wan, L; Chye Chung, G; Chew Ming, W; Wan Ahmad Hafiz Wan M, A; Soo Kun, L. (2020) SINGLE CENTRE EXPERIENCE ON ULTRA-LOW DOSE THYMOGLOBULIN AS AN INDUCTION AGENT IN LOW IMMUNOLOGICAL RISK LIVING KIDNEY TRANSPLANT RECIPIENTS. Transplantation, - Extended Abstract

RESEARCH PROJECT


National
  1. 2021 - 2026, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation (2021-10-26 - 2026-02-27) ( Co-Researcher)
  2. 2019 - 2021, Private Funding
    A multicentre observational study to evaluate the clinical performance and safety of a new dialysis fluid (SOFT FLOW SC) used in CAPD and automated peritoneal dialysis cycler (Lucenxia Intellis) system in patients with end stage kidney disease (SOFT FLOW SC Trial) ( Consultant)
  3. 2019 - 2021, MSN research grant 2019
    Height adjusted total kidney volume (HtTKV) using MRI and age at HtTKV in predicting decline of renal function in Malaysian autosomal dominant polycystic kidney disease (ADPKD) cohort ( Principal Investigator(PI))
  4. 2019 - 2020, Private Funding
    Utilization of HCV Core antigen in Haemodialysis patients to identify patients eligible for HCV treatment. ( Consultant)
International
  1. 2019 - 2023, International Funding
    EMPA-KIDNEY: the study of heart and kidney protection with empagliflozin ( Consultant)
  2. 2020 - 2022, International Funding
    Open-label randomised controlled trial of Efepoetin Alfa for treatment of Anaemia associated with Chronic Kidney Disease Patients Not On Dialysis (ND-CKD). A non-inferiority trial compared to Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) [Protocol No. GXE4KGBio-001] ( Consultant)
  3. 2019 - 2021, International Funding
    A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison with Mycophenolate Mofetil and Corticosteroids in Subjects with Class III/IV V Lupus Nephritis ( Consultant)
  4. 2017 - 2019, International Funding
    A study to assess the Renoprotective Effects of the SGLT2 INHIBITOR DAPAGLIFLOZIN in Non-Diabetic Patients with Proteinuria: a Randomized Double Blind 6 weeks Cross-Over Trial ( Consultant)
University
  1. 2019 - 2022, Private Funding
    Height Adjusted Total Kidney Volume (httkv) Using Mri And Age At Httkv In Predicting Decline Of Renal Function In Malaysian Autosomal Dominant Polycystic Kidney Disease (adpkd) Cohort ( Principal Investigator(PI))

PAPER PRESENTED


INVITED SPEAKER
  1. AI in Vascular Access, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Society of Dialysis Synergy, Singapore (National) (13 Sep 2024 - 15 Sep 2024)
  2. US guided cannulation : Teaching nurses to improve uptake, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society of Malaysia and Society of Dialysis Access Synergy, Singapore (National) (13 Sep 2024 - 15 Sep 2024)
  3. Vascular access scanning techniques and selecting best cannulation site, Ultrasound practice in dialysis nursing, AIM Medical supplies and national kidney foundation (NKF) (National) (18 May 2024 - 18 May 2024)
  4. Understanding Human Disease, Continuous Education and Training (CET), CET Academy (International) (26 Sep 2019 - 27 Sep 2019)
  5. Nephrology, Part 1 MRCP Preparatory course, Department of Medicine, Hospital Melaka, Pertubuhan Pendidikan Perubatan Lepasan Ijazah, and Melaka-Manipal Medical College (National) (03 Aug 2019 - 04 Aug 2019)
  6. Part 1 MRCP perparatory course (Pharmacology), Part 1 MRCP Preparatory course , Department of Medicine, Hospital Melaka in collaboration with Melaka Manipal Medical University, and Melaka Hospital Post Graduate Society (Others) (11 Aug 2018 - 11 Aug 2018)
ORAL PRESENTER
  1. EFFECTIVENESS AND SUSTAINABILITY OF A MULTIDISCIPLINARY CARE MODEL FOR PATIENT WITH HEMODIALYSIS ACCESS DYSFUNCTION, 5th Kuala Lumpur Vascular Access Conference, Vascular Society of Malaysia (VSM) (National) (09 Dec 2022 - 10 Dec 2022)
  2. PARAFFIN WASHOUT IMMUNOFLUORESCENCE TECHNIQUE IMPROVES SAFETY AND ADEQUACY OF TRANSPLANT KIDNEY BIOPSY, 36th Annual Congress of Malaysian Society of Nephrology, MSN (National) (23 Jul 2021 - 24 Jul 2021)
  3. HEIGHT ADJUSTED TOTAL KIDNEY VOLUME (HTTKV) USING MRI AND AGE AT HTTKV IN PREDICTING DECLINE OF RENAL FUNCTION IN PATIENT WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE., 36th Annual Congress of Malaysian Society of Nephrology, MSN (National) (23 Jul 2021 - 24 Jul 2021)
  4. SERUM PROTEIN ELECTROPHORESIS ANALYSIS IN CHRONIC KIDNEY DISEASE WITH AND WITHOUT DIABETES MELLITUS, 36th Annual Congress of Malaysian Society of Nephrology, Malaysian Society of Nephrology (MSN) (National) (23 Jul 2021 - 24 Jul 2021)
  5. Hepatitis C Virus Core Antigen As Alternative Diagnostic Algorithm For Active HCV Infection Among Haemodialysis Population: Cost Implications, Annual Scientific Meeting of Malaysian Society if Gastroenterology & Hepatology, Malaysian Society if Gastroenterology & Hepatology (National) (27 Nov 2020 - 29 Nov 2020)
  6. OUTCOMES OF ABO INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION: MULTI-CENTRE EXPERIENCE IN MALAYSIA, 35th Annual Congress of Malaysia Society of Nephrology July 2019, Malaysian Society of Nephrology (National) (11 Jul 2019 - 14 Jul 2019)
  7. Short-term Outcomes of ABO-incompatible (ABOi) Living Donor Kidney Transplantation (LDKT): Single-centre Experience in Malaysia, 22nd Annual Scientific Meeting of Malaysian Society of Transplantation , Malaysian Society of Transplantation (National) (25 Apr 2019 - 27 Apr 2019)
  8. THE UTILITY OF SERUM FREE LIGHT CHAIN AS SURROGATE MARKER FOR RENAL ACTIVITY IN LUPUS NEPHRITIS, 34th Annual Congress of Malaysia Society of Nephrology, Malaysian Society of Nephrology (National) (27 Jul 2018 - 29 Jul 2018)
  9. BODY COMPOSITION MONITORING: DOES IT ADD VALUE TO CLINICAL ASSESSMENT OF DRY WEIGHT IN HEMODIALYSIS PATIENTS?, 34th Annual Congress of Malaysia Society of Nephrology, Malaysian Society of Nephrology (National) (27 Jul 2018 - 29 Jul 2018)
POSTER PRESENTER
  1. Venous Congestive Encephalopathy in a Case of Acute on Chronic Total Central Vein Occlusion in Patient with Left Brachiobasilic Arteriovenous Fistula, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Dialysis Access Synergy (DASY)Singapore (National) (14 Sep 2024 - 15 Sep 2024)
  2. Therapeutic Percutaneous Endovascular Angioplasty Balloon Tamponade In Catheter Related Left Brachiocephalic Vein Perforation, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Dialysis Access Synergy (DASY)Singapore (National) (14 Sep 2024 - 15 Sep 2024)
  3. Utilisation of aspiration thrombectomy device in cases with high clot burden and chronic restrictive lung disease, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Dialysis Access Synergy (DASY)Singapore (National) (14 Sep 2024 - 15 Sep 2024)
  4. Novel Technique of Assisted Maturation for Immature Native Arteriovenous Fistula: The Machine Assisted Maturation (MAM) - A Case Report, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Dialysis Access Synergy (DASY)Singapore (National) (14 Sep 2024 - 15 Sep 2024)
  5. Novel percutaneous endovascular direct intraclot-thrombolysis coupled with modified aspiration thrombectomy technique in a series of thrombosed arteriovenous fistula with large aneurysm and high clot-burden, Kuala Lumpur Vascular Access Conference (KLVAC) in conjunction with the Dialysis Access Synergy (DASY) KLVAC+DASy 2024, Vascular Society Malaysia and Dialysis Access Synergy (DASY)Singapore (National) (14 Sep 2024 - 15 Sep 2024)
  6. Applicability of Mayo s autosomal dominant polycystic kidney disease prognostic tool in the Southeast Asian ADPKD population, ASN Kidney Week 2023, American Society of Nephrology (International) (01 Nov 2023 - 05 Nov 2023)
  7. SAFETY AND ADEQUACY OF TRANSPLANT KIDNEY BIOPSY BY NEPHROLOGISTS AT A TERTIARY TEACHING HOSPITAL, 36th Annual Congress of Malaysian Society of Nephrology, MSN (National) (23 Jul 2021 - 24 Jul 2021)
  8. Second Living Related Renal Transplantation for a Hepatitis C Virus-Infected Recipient After Achieving 12th Week Sustained Virologic Response with Direct-Acting Antiviral Therapy: An Index Case Report., 23rd Annual Scientific of Malaysian Society of Transplantation, Malaysian society of Transplantation (National) (19 Sep 2020 - 20 Sep 2020)
  9. Pregnancy in chronic allograft nephropathy with recurrent UTI - A case report, 22nd Annual Scientific Meeting of Malaysian Society of Transplantation , Malaysian Society of Transplantation (National) (25 Apr 2019 - 27 Apr 2019)
  10. UTILITY OF EVEROLIMUS AND CMV-QUANTIFERON MONITORING IN MANAGING RECURRENT CYTOMEGALOVIRUS (CMV) INFECTION IN A KIDNEY TRANSPLANT RECIPIENT., 34th Annual Congress of Malaysia Society of Nephrology, Malaysian Society of Nephrology (National) (27 Jul 2018 - 29 Jul 2018)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2022) Ketogenic Diet Shake Associated Acute Interstitial Nephritis, International, (Reviewer)
  2. (2021) Penemuduga MBBS Saluran Terbuka Universiti Malaya Satu Sesi 20212022, University, (Internal Assessor)
  3. (2021) Temuduga Kemasukan Ke Program Sarjana Muda Perubatan dan Sarjana Muda Pembedahan (MBBS) Bagi Sesi 2021/2022, University, (Internal Assessor)
  4. (2021) Article Reviewer, International, (Reviewer)
  5. (2021) Reviewer for the pre-publication manuscript Provision of Local Food-based Formula for Acceptability and Nutrition Intake in Hemodialysis Patients: A Pilot Study for Current Research in Nutrition and Food Science (WOS);, (Reviewer)
  6. (2021) Chairperson Proposal Defence Evaluation, (Internal Examiner)
  7. (2020) Bachelor of Dental and Surgery (BDS) Year III Professional Examination, (Internal Examiner)
  8. (2020) Root cause analaysis expert committee, (Reviewer)
  9. (2020) PELANTIKAN PEMERIKSA REQUIRED SUMMATIVE ASSESSMENT 2 (RSA 2) SESI 2019/2020 PERINGKAT 2, IJAZAH SARJANA MUDA PERUBATAN DAN SARJANA MUDA PEMBEDAHAN (MBBS) : KERTAS OSCE 2 (SOALAN 2) , (Internal Examiner)
  10. (2020) Kertas OSCE bagi peperiksaan peringkat 1 sarjana muda perubatan dan sarjana muda pembedahan (MBBS) Sesi 2019/2020, (Internal Examiner)
  11. (2020) Reviewer and an expert panel of the medical board member, (Reviewer)
  12. (2018) Honorary examiner for PACES MOCK EXAM 1/2018 Hospital Melaka , (External Examiner)
  13. (2018) Honorary examiner for 1st ACE PACES preparatory course 29/09/2018 Hospital Melaka, (External Examiner)
  14. (2018) Required summative assessment 2 (RSA 2) Peringkat 2 Sarjana Muda Perubatan Dan Sarjana Muda Pembedahan (MBBS), SESI 2018, (Internal Examiner)
Contribution to external organisation
  1. (2021) Fellowship in Nephrology (UMMC) Curriculum design, Division of Nephrology, Medical Department, UMMC
  2. (2021) Hemodialysis short course 2021: Intradialytic events and vascular access care , Division of nephrology UMMC and Renal-Sig (MNA)
  3. (2020) Clinical case finders for Master of Medicine Bahagian II (dan I), University of Malaya
  4. (2020) Project leader/Co-organiser for HD short course 2020 , Malaysian Nursing Association
  5. (2020) REVISE Nephrology, REVISE NEPHROLOGY
  6. (2019) A Dialysis Outreach Program for Transplantation., aDOPT, University of Malaya
  7. (2019) Clinical coordinator for MRCP PACES examination 2019/3, Royal colleges of physicians of the United Kingdom
  8. (2019) Clinical case coordinator UMMP 3.2 Supplementary barrier assessment cohort 2014, Faculty of Medicine
  9. (2018) Hemodialysis short course: Dialysis vascular access and CKD-MBD. , Malaysian Nursing Association
Media appearance
  1. (2021) Invited Speaker by Metronic for Optimizing Catheter Insertion and Catheter Care in Aki Patients: Prolonging The Longevity of Acute Dialysis Catheter, International, (Discourse)
  2. (2021) Webinar Kidney Care 2021, National, (Discourse)
  3. (2021) Speaker for World Kidney Day 2021: Kdigo Ckd-Dm Cpg 2020, University, (Discourse)

SUPERVISION


Postgraduate Student
Master
  1. (2020) UTILIZATION OF HCV CORE ANTIGEN IN HEMODIALYSIS PATIENTS TO IDENTIFY PATIENTS ELIGIBLE FOR HCV TREATMENT, WONG XUE ZHENG
  2. (2019) UTILIZATION OF HCV CORE ANTIGEN IN HEMODIALYSIS PATIENTS TO IDENTIFY PATIENTS ELIGIBLE FOR HCV TREATMENT, JOHNNY WONG
Under Graduate Students
  1. (2024) Practices, Cheah Xu Theng

TEACHING


Master
  1. (2020) CRN9001 - Basic Nephrology - Comorbidities Associated With Kidney Disease: Cardiovascular Abnormalities, Hypertension & Diabetes Mellitus
  2. (2020) CRN9001 - Complications of Hemodialysis
  3. (2020) CRN9001 - Vascular Access for Hemodialysis
  4. (2020) CRN9002 - Infection Control in Hemodialysis for Patient With Hepatitis B, C, and Hiv
Bachelor
  1. (2020) UMMP - 3.2 Clinical Bedside
  2. (2019) BDS - Nephrology I: Acute Kidney Injury and Chronic Kidney Disease
  3. (2019) MIA2001 - Medical Sciences 2 (Stage 2): Renal & Urology (Cohort 2017)
  4. (2019) MID2010 - Basic Medical Sciences Iv
  5. (2019) UMMP - Ummp 3.2: Year of 2014/2019: Posting K, Group D
  6. (2019) UMMP - Stage 2: Block 8 Endocrine, Nutrition & Sexual Health Clinical Days (Cohort 2017)
  7. (2019) UMMP - Ummp Stage 3.1 - Medicine Posting Class of 2016/2021: Session 2018/2019 (Posting D)
  8. (2019) UMMP2901 - Bock 9: Renal and Urology - Clinical Approach in Hematuria
  9. (2018) MIA2001 - Medical Sciences 2 (Stage 2): Endocrinology, Nutrition & Sexual Health (Cohort 2016)
  10. (2018) MIA2001 - Medical Sciences 2 (Stage 2): Renal & Urology (Cohort 2016)
  11. (2018) MID2010 - Basic Medical Sciences Iv
  12. (2018) UMMP - Ummp 3.2: Year of 2013/2018: Posting H, Group D
  13. (2018) UMMP - Ummp 3.2 Internal Medicine Class of 2014/2019: Posting K
  14. (2018) UMMP - Ummp 3.2 Internal Medicine Class of 2014/2019: Posting L
  15. (2018) UMMP - Ummp Stage 3.1 - Medicine Posting Class of 2015/2020: Session 2017/2018 (Posting F) Group a&E
  16. (2018) UMMP - Ummp Stage 3.1 - Medicine Posting Class of 2016/2021: Session 2018/2019 (Posting B); Crs
Others
  1. (2019) MDA2001 - Management of Acute Renal Failure and Chronic Renal Failure
  2. (2018) CRN1001 - Basic Nephrology - Comorbidities Associated With Kidney Disease: Cardiovascular Abnormalities, Hypertension & Diabetes Mellitus

SOCIAL RESPONSIBILITY ACTIVITIES


  • Monthly Donation: Tzu Chi 2020, (01 Jan 2020 - 31 Dec 2020)
  • A Dialysis Outreach Program for Transplantation: Facilitator and Co-Advisor, (05 May 2019 - 05 May 2019)
  • Monthly Donation: Tzu Chi 2019, (01 Jan 2019 - 31 Dec 2019)